- PMLiVE

Longevity lessons

The secret to corporate longevity isn’t growth, it’s survival

- PMLiVE

The fight against antimicrobial resistance

By Jonathan Cooke

- PMLiVE

Building a brighter future with patient support programmes

By Danny Buckland

- PMLiVE

AI: powering healthcare, empowering patients Physician perceptions of AI and the future of pharma

In the face of the coronavirus, innovative technologies such as artificial intelligence (AI) and machine learning (ML) have proven vital for the protection and promotion of public health.According to a...

- PMLiVE

Cannes Lions shows health creative is becoming an art form

If you ever want an example of art imitating life, look no further than Cannes Lions 2022. Because just like life these past two years – in fact possibly because...

FlyPharma Europe unites pharma, biotech and bio pharma with air cargo logistics

In the middle of the pandemic, the pharma industry was under pressure to not just maintain but increase its existing business, while navigating the logistical challenges that COVID-19 placed in...

- PMLiVE

Transforming clinical trials to accelerate drug development

There are great opportunities for the UK to take the learnings from the pandemic and build on our competitive advantages to strengthen and grow our clinical research environment. The aim...

- PMLiVE

Are we the masters or servants of omnichannel engagement?

I think very few people will have failed to notice that our industry is currently in somewhat of a turmoil, as each company and team look at how they can...

- PMLiVE

Environment: where does the pharmaceutical industry stand?

Industry is taking environmental commitments more seriously, especially after pivotal events such as COP26 and publication of the IPCC’s cautionary ‘now or never’ report.Pharma is no exception, with some of...

- PMLiVE

That ‘don’t’ impress me much

I am going to come straight out with it – when it comes to evaluation, I am not impressed by impressions.By the time you are reading this, many of you...

- PMLiVE

How the Royal Society’s EiR programme can help to drive UK innovation

Earlier this year I attended a meeting of the latest cohort of Entrepreneurs in Residence (EiR) at the Royal Society, the UK’s national academy of sciences.I was struck by the...

- PMLiVE

My body. My choice. Are we all talking about the same thing?

By now you have all heard. In fact, the world has heard. The US Supreme Court has overturned Roe v Wade. The constitutional right to abortion in the US no...

- PMLiVE

Strategic commitment

Life sciences businesses, such as pharmaceuticals and medical technology, are characterised by a high proportion of educated people in roles that have high discretion. That is, you can’t tell them...

- PMLiVE

Achieving communication excellence by targeting the right channel at the right time

By Danny Buckland

- PMLiVE

A creative awakening – how pharma is bringing innovation to the patient journey

By Danny Buckland